PCSK9 and coronary artery disorder: While PCSK9 gain-of-function (GOF) mutations can result in high plasma levels of LDL [5], PCSK9 loss-of-function (LOF) mutations lead to life-long reduction of circulating LDL and can significantly reduce major CHD events in humans [6, 7].